MCID: FCL003
MIFTS: 30

Facial Hemiatrophy malady

Category: Neuronal diseases

Aliases & Classifications for Facial Hemiatrophy

About this section

Aliases & Descriptions for Facial Hemiatrophy:

Name: Facial Hemiatrophy 11 13 37 66
 
Parry-Romberg Syndrome 11

Classifications:



External Ids:

Disease Ontology11 DOID:1757
MeSH37 D005150
SNOMED-CT60 29868009, 95834000

Summaries for Facial Hemiatrophy

About this section
MalaCards based summary: Facial Hemiatrophy, also known as parry-romberg syndrome, is related to heart disease and hemifacial atrophy, progressive, and has symptoms including ataxia and oral manifestations. An important gene associated with Facial Hemiatrophy is COPS2 (COP9 Signalosome Subunit 2). Affiliated tissues include brain, breast and heart.

Related Diseases for Facial Hemiatrophy

About this section

Diseases related to Facial Hemiatrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 55)
idRelated DiseaseScoreTop Affiliating Genes
1heart disease29.8CD40LG, KANTR
2hemifacial atrophy, progressive11.2
3liver lipoma10.4ARHGEF1, HMGA2
4keratoconjunctivitis sicca10.2CD40LG, HMGA2
5autism spectrum disorder10.2CD40LG, COL17A1
6chandler syndrome10.2ARHGEF1, KANTR
7adenosquamous breast carcinoma10.2ARHGEF1, KANTR
8impetigo10.2CD40LG, COL17A1
9malignant histiocytosis10.2CD40LG, COL17A1
10steroid lipomatosis10.2HMGA2, KANTR
11acrofrontofacionasal dysostosis10.1COPS2, KANTR
12linear scleroderma10.1
13rickettsialpox10.1CD40LG, KANTR
14pompholyx10.1CD40LG, KANTR
15brachial plexus neuropathy10.0CD40LG, KANTR
16sporotrichosis10.0CD40LG, COL17A1
17rocky mountain spotted fever10.0CD40LG, KANTR
18urinary schistosomiasis10.0CD40LG, KANTR
19tinea cruris10.0COL17A1, KANTR
20american histoplasmosis10.0CD40LG, KANTR
21lynch syndrome10.0CD40LG, KANTR
22cervicitis10.0
23cerebritis10.0
24localized scleroderma10.0
25adult brain stem glioma9.9KANTR, PRRT2
26intestinal pseudo-obstruction9.9CD40LG, KANTR
27blood group incompatibility9.9CD40LG, COL17A1
28oesophagostomiasis9.8CD40LG, KANTR
29ellis-van creveld syndrome9.8
30alopecia9.8
31keratopathy9.8
32systemic scleroderma9.8
33juvenile glaucoma9.8
34sarcoma9.8
35enophthalmos9.8
36hypertrophic cardiomyopathy9.8
37optic neuritis9.8
38bell's palsy9.8
39facial paralysis9.8
40congenital heart disease9.8
41neuritis9.8
42epilepsy9.8
43astrocytoma9.8
44myopathy9.8
45encephalitis9.8
46pemphigoid gestationis9.8
47cardiomyopathy9.8
48headache9.8
49myoclonus9.8
50spinocerebellar degeneration9.8

Graphical network of the top 20 diseases related to Facial Hemiatrophy:



Diseases related to facial hemiatrophy

Symptoms for Facial Hemiatrophy

About this section

UMLS symptoms related to Facial Hemiatrophy:


ataxia, oral manifestations

Drugs & Therapeutics for Facial Hemiatrophy

About this section

Drugs for Facial Hemiatrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SufentanilPhase 316656030-54-741693
Synonyms:
56030-54-7
60561-17-3 (citrate)
AC1L26AJ
AC1Q5I7B
C08022
C22H30N2O2S
CHEBI:127638
CHEBI:9316
CHEMBL658
CID41693
Chronogesic
D05938
DB00708
HSDB 6760
L000580
LS-175693
MolPort-004-286-008
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
 
N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
Oprea1_120838
Oprea1_246787
PDSP1_001741
PDSP2_001724
R 30730
R-30730
SUFENTANIL
Sufentanil
Sufentanil (USAN/INN)
Sufentanil Citrate
Sufentanil [USAN:BAN:INN]
Sufentanilo
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanyl
UNII-AFE2YW0IIZ
2
LevobupivacainePhase 316027262-47-192253
Synonyms:
(-)-Bupivacaine
(-)-bupivacaine
(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(S)-1-Butyl-2',6'-pipecoloxylidide
(S)-Bupivacaine
(S)-bupivacaine
27262-47-1
27262-48-2
AC1L3NQM
BIDD:GT0471
C07887
C18H28N2O
CAS-18010-40-7
CHEBI:6149
CID92253
D08116
 
DB01002
L(-)-Bupivacaine
L-(-)-1-Butyl-2',6'-pipecoloxylidide
L-(-)-Bupivacaine
L-(-)-bupivacaine
LS-109843
LS-187025
LS-187789
Levobupivacaine
Levobupivacaine (INN)
Levobupivacaine [INN:BAN]
Levobupivacaine hydrochloride
MolPort-004-959-713
NCGC00016733-01
NCGC00159482-02
Novabupi
Novabupi (TN)
3
BupivacainePhase 310562180-92-9, 38396-39-32474
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
(┬▒)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
15233-43-9
2180-92-9
38396-39-3
AB00053674
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AKOS001637202
AR-1A0242
Anekain
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bio-0886
Bloqueina
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine (INN)
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine [INN:BAN]
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
Carbostesin
D07552
DB00297
DL-Bupivacaine
DUR-843
 
DepoBupivacaine
DivK1c_000758
EINECS 218-553-3
EINECS 253-911-2
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
MLS001361336
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
SMR000058218
SPBio_001558
SPBio_002489
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Spectrum_001524
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
bupivacaine
cBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
racemic bupivacaine
4vestipitantPhase 29334476-46-9
5
substance PPhase 223933507-63-044359816
Synonyms:
 
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
6neurokinin APhase 2242
7
SimvastatinPhase 150379902-63-954454
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
79902-63-9
AC-1530
AC1L1H1F
AKOS005111006
ARONIS24119
BCBcMAP01_000007
BIDD:GT0769
BPBio1_001001
BRD-K22134346-001-05-8
BRN 4768037
BSPBio_000909
BSPBio_002337
Bio-0672
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
C25H38O5
CCRIS 7558
CHEBI:9150
CHEMBL1064
CID54454
CPD000718785
Cholestat
Coledis
Colemin
Corolin
D00434
D019821
DRG-0320
Denan
DivK1c_006991
Eucor
HMS1570N11
HMS1922H13
HMS2089D12
HMS2093E06
HSDB 7208
InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
KBio1_001935
KBio2_002197
KBio2_004765
KBio2_007333
KBio3_001557
KBioGR_001244
KBioSS_002197
KS-1113
Kolestevan
L 644128-000U
LS-46264
Labistatin
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
MK 0733
MK 733
MK-0733
MK-733
MK733
MLS001304029
MLS001333077
MLS001333078
 
MLS002154038
Medipo
Modutrol
MolPort-002-507-345
MolPort-002-885-862
NCGC00017324-01
NCGC00017324-02
NCGC00017324-03
Nivelipol
Nor-Vastina
Pantok
Pepstatin
Prestwick0_000865
Prestwick1_000865
Prestwick2_000865
Prestwick3_000865
Prestwick_171
Rechol
Rendapid
S1792_Selleck
S6196_SIGMA
SAM002589969
SMR000718785
SPBio_001881
SPBio_002830
SPECTRUM1504236
STK801938
Simcor
Simovil
Simvast CR
Simvastatin
Simvastatin & Primycin
Simvastatin (JAN/USP/INN)
Simvastatin [USAN:INN:BAN]
Simvastatin [Usan:Ban:Inn]
Simvastatin lactone
Simvastatin, Compactin
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
Sivastin
SpecPlus_000895
Spectrum2_001671
Spectrum3_000669
Spectrum4_000632
Spectrum5_001428
Spectrum_001717
Statin
Synvinolin
TNP00259
UNII-AGG2FN16EV
Valemia
Vasotenal
Velostatin
Vytorin
ZINC03780893
Zocor
Zocor (TN)
Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin
Zocord
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta
nchembio790-comp16
simvastatin
8Atorvastatin CalciumPhase 1727134523-03-8
9
Menthol21842216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol

Interventional clinical trials:

(show all 23)
idNameStatusNCT IDPhase
1Trial Comparing Navigated and Conventional Implantation Techniques in Knee Replacement SurgeryRecruitingNCT00431509Phase 4
2Deambulatory Epidural During the LabourRecruitingNCT02264834Phase 3
3The Effect of Human Adipose Tissue-derived MSCs in Romberg's DiseaseCompletedNCT01309061Phase 2
4Vestipitant 28-day Tolerance StudyCompletedNCT00992160Phase 2
5To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary InsomniaCompletedNCT00426816Phase 2
6Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteersCompletedNCT01030939Phase 1
7A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.CompletedNCT01299597Phase 1
8Bioequivalence and Food Effect Study in Healthy VolunteersCompletedNCT00495274Phase 1
9Applicability of Kinect Sensor® in the Rehabilitation of Balance in the ElderlyCompletedNCT02436837
10Analysis of Balance in the Aging ProcessCompletedNCT00906711
11Clinical Effect Size of an Educational Intervention in the Home and Compliance on People Who Suffer From StrokeCompletedNCT01980641
12Influences of Balance Training With a Dynamometric Platform in Total Knee ArthroplastyCompletedNCT02734225
13Improving Muscle Assessment in Older Adults - The "Can We Build a Better Mouse Trap?" StudyCompletedNCT02295241
14Efficacy of Eccentric Resistance Training in Persons With Knee OsteoarthritisCompletedNCT02350387
15Effects of a Fall Preventive Exercise Program on Intrinsic Fall Risk Factors in Healthy Older Adults.CompletedNCT01906034
16Relationship Between Musculoskeletal, Sensorimotor and Functional Factors and Nonspecific Chronic Neck PainRecruitingNCT02789631
17Effect of High Altitude Exposure, Acclimatization and Re-exposure on Postural Control in LowlandersRecruitingNCT02730182
18Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA RepositoryRecruitingNCT01808937
19IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.RecruitingNCT02130349
20Effect of Oculomotor and Gaze Stability Exercises on the Improvement of Balance After StrokeEnrolling by invitationNCT02280980
21Role of Mesenchymal Stem Cells in Fat GraftingNot yet recruitingNCT02494752
22The Effect of Obstructive Sleep Apnea Treatment on Dizziness, VertigoNot yet recruitingNCT02685579
23Comparative Study About the Effect of Aquatic Therapy vs Land-based Therapy in Women With FibromyalgiaNot yet recruitingNCT02695875

Search NIH Clinical Center for Facial Hemiatrophy


Cochrane evidence based reviews: facial hemiatrophy

Genetic Tests for Facial Hemiatrophy

About this section

Anatomical Context for Facial Hemiatrophy

About this section

MalaCards organs/tissues related to Facial Hemiatrophy:

34
Brain, Breast, Heart, Eye

Animal Models for Facial Hemiatrophy or affiliated genes

About this section

Publications for Facial Hemiatrophy

About this section

Articles related to Facial Hemiatrophy:

(show top 50)    (show all 103)
idTitleAuthorsYear
1
Overlap between linear scleroderma, progressive facial hemiatrophy and immune-inflammatory encephalitis in a paediatric cohort. (25851111)
2015
2
Pemphigoid gestationis in a female with progressive facial hemiatrophy: microchimerism as a speculative shared background is disputable. (22535610)
2012
3
Microsurgical correction of progressive facial hemiatrophy using free anterolateral thigh adipofascial flap. (23154348)
2012
4
Three-dimensional imaging of progressive facial hemiatrophy (Parry-Romberg syndrome) with unusual conjunctival findings. (22232729)
2011
5
Progressive facial hemiatrophy revisited: a role for sympathetic dysfunction. (21911700)
2011
6
Progressive facial hemiatrophy - a case series. (22121278)
2011
7
Superficial temporal fascial flap plus lipofilling for facial contour reconstruction in bilateral progressive facial hemiatrophy. (20333522)
2010
8
Teaching NeuroImages: progressive facial hemiatrophy (Parry-Romberg syndrome) with ipsilateral cerebral hemiatrophy. (20083791)
2010
9
Ellis-van Creveld syndrome with facial hemiatrophy. (20445298)
2010
10
Rare cause of facial asymmetry. Progressive facial hemiatrophy. (15842131)
2005
11
Progressive facial hemiatrophy: a complex disorder not only affecting the face. A report in a monozygotic male twin pair. (15918232)
2004
12
Facial hemiatrophy--a report of 5 cases. (15328992)
2003
13
Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them? (12224693)
2002
14
Progressive facial hemiatrophy (Parry-Romberg syndrome). (11820053)
2001
15
Progressive facial hemiatrophy after epileptic seizures. (11020643)
2000
16
Linear scleroderma en Coup de Sabre. Relationship with progressive facial hemiatrophy (PFH). (10599329)
1999
17
Progressive facial hemiatrophy: abnormality of intracranial vasculature. (9633763)
1998
18
Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome). (9127045)
1997
19
Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea. (9144696)
1997
20
Central sympathetic dysregulation and immunological abnormalities in a case of progressive facial hemiatrophy (Parry-Romberg disease). (8520214)
1995
21
MR of brain involvement in progressive facial hemiatrophy (Romberg disease): reconsideration of a syndrome. (8141046)
1994
22
Duane's retraction syndrome with facial hemiatrophy. (8294337)
1993
23
Progressive facial hemiatrophy: report of five cases and biochemical analysis of connective tissue. (1446085)
1992
24
The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions? (1404118)
1992
25
Progressive facial hemiatrophy (Parry-Romberg syndrome) and antibodies to Borrelia. (1918499)
1991
26
Surgical treatment of progressive facial hemiatrophy. (1696052)
1990
27
Facial hemiatrophy (Parry-Romberg syndrome) and hypertrophic cardiomyopathy. (3182718)
1988
28
A case of facial hemiatrophy associated with linear scleroderma and homolateral masseter spasm. (3570725)
1987
29
Progressive facial hemiatrophy (Parry-Romberg syndrome). (7319766)
1981
30
Masticatory spasm in facial hemiatrophy. (7436363)
1980
31
Congenital nonprogressive facial hemiatrophy with ipsilateral eye abnormalities and juvenile glaucoma. (110207)
1979
32
Progressive facial hemiatrophy (Parry-Romberg syndrome). (1028996)
1976
33
Refractive change as the initial sign of progressive facial hemiatrophy. (1146951)
1975
34
Progressive facial hemiatrophy (a case report). (4500006)
1973
35
Painful ophthalmoplegia and enophthalmos due to metastatic carcinoma: simulation of essential facial hemiatrophy. (4326705)
1971
36
A new treatment for facial hemiatrophy in children by injections of dimethylpolysiloxane fluid. (5623679)
1967
37
Facial hemiatrophy (Parry-Romberg syndrome). (5924586)
1966
38
Facial hemiatrophy. (5222736)
1965
39
AN INJECTION TECHNIQUE FOR THE TREATMENT OF FACIAL HEMIATROPHY. (14310534)
1965
40
Facial hemiatrophy associated with Bell's palsy. (5215049)
1965
41
OCULAR MANIFESTATIONS OF FACIAL HEMIATROPHY. (14064456)
1963
42
SCLERODERMIA AND FACIAL HEMIATROPHY. (14162093)
1963
43
Facial hemiatrophy with alopecia (Romberg's syndrome) associated with heterochromic cyclitis (Fuchs' syndrome)]. (13611220)
1958
44
Progressive facial hemiatrophy. (14383951)
1955
45
The use of large buried pedicled flaps of dermis and fat; clinical and pathological evaluation in the treatment of progressive facial hemiatrophy. (13055476)
1953
46
The nature of agenesis and deficiency of parts; the influence of intrinsic factors in disease when development of the body is abnormal, as illustrated by agenesis of the digits, facial hemiatrophy, and cerebral agyria and microgyria. (14923835)
1952
47
Facial hemiatrophy. (20277335)
1946
48
The Association of Optic Neuritis, Facial Paralysis, and Facial Hemiatrophy. (16693016)
1934
49
Case of Facial Hemiatrophy. (19984475)
1925
50
A Case of Facial Hemiatrophy: Lack of Development of the Breast on the same side. (19984453)
1925

Variations for Facial Hemiatrophy

About this section

Expression for genes affiliated with Facial Hemiatrophy

About this section
Search GEO for disease gene expression data for Facial Hemiatrophy.

Pathways for genes affiliated with Facial Hemiatrophy

About this section

GO Terms for genes affiliated with Facial Hemiatrophy

About this section

Biological processes related to Facial Hemiatrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1regulation of growthGO:00400089.6HMGA2, PTCH1
2cell proliferationGO:00082839.4ARHGEF1, COPS2, HMGA2

Sources for Facial Hemiatrophy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet